International Guillain-Barré Syndrome Outcome Study



Status:Recruiting
Healthy:No
Age Range:Any
Updated:1/6/2017
Start Date:May 2012
End Date:January 2019
Contact:Bianca van den Berg, Drs, MD
Email:gbsstudies@erasmusmc.nl
Phone:0031107042209

Use our guide to learn which trials are right for you!

International GBS Outcome Study (IGOS): A Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).

International GBS Outcome Study (IGOS) is a study conducted by the members of the
Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease
course and outcome in Guillain-Barré syndrome (GBS).

The IGOS aims to identify clinical and biological determinants and predictors of disease
course and outcome in individual patients with Guillain-Barré syndrome, as early as possible
after onset of disease.

GBS is a post-infectious immune-mediated polyradiculoneuropathy with a highly diverse
clinical course and outcome despite partially effective forms of treatment(immunoglobulins
and plasma exchange). Outcome in patients with GBS has not improved in the last two decades.
At present about 10 to 20% of patients remain severely disabled and about 5% die. One
explanation for this stagnation is the highly variable clinical course of GBS and the lack
of knowledge about the factors that determine the clinical course in individual patients
with GBS. GBS may consist of distinct pathogenic subgroups, in which disease onset and
progression is influenced by different types of preceding infections, anti-neural antibodies
and genetic polymorphisms. Optimal treatment of individual patients may depend on the
pathogenesis and clinical severity. Patients with severe forms of GBS may possibly need more
intensive treatment to recover. Patients with a milder course that fully recover after
standard therapy could suffer from possibly more side effects of more aggressive forms of
treatment. This could only be possible if there are prognostic models that accurately
predict the clinical course in individual patients. Ideally such models should be based on
clinical and biological predictors that are strongly associated with disease course and
known as early as possible in the acute phase of illness, when treatment with
immunomodulatory therapy is most effective. Prognostic models could help to guide selective
trials in specific GBS subtypes. Because of this it will be possible to treat GBS with more
effective and more individual therapy.

This study aims to identify clinical and biological determinants and predictors of disease
course and outcome in individual patients with Guillain-Barré syndrome, as early as possible
after onset of disease. This information will be used to understand the diversity in
clinical presentation and response to treatment of GBS. This information will also be used
to develop new prognostic models to predict the clinical course and outcome accurately in
individual patients with GBS.

To address these research questions it is required to conduct a prospective study with
standardized collection of clinical data and biomaterials from a large group of well-defined
GBS patients during a long follow-up period. Such an extensive study in a relatively rare
disease as GBS can be addressed only by intensive international collaboration.

Inclusion Criteria:

- Fulfil diagnostic criteria for GBS of National Institute of Neurological Disorders
and Stroke (NINDS). Patients with Miller Fisher syndrome and all other variants of
GBS, including overlap syndromes, can be included.

- Inclusion of all males and females of all ages, independent of disease severity and
treatment

- Inclusion within two weeks of onset of weakness

- Inclusion of patients transferred from another hospital if the stay in the first
hospital was less than one week

- Opportunity to conduct a follow-up of at least one year

- Informed consent of patient or, in case of children, of parents or legal guardians

Exclusion Criteria:

- There are no exclusion criteria
We found this trial at
27
sites
Dallas, Texas 75390
Principal Investigator: Diana Castro
?
mi
from
Dallas, TX
Click here to add this to my saved trials
1 South Prospect Street
Burlington, Vermont 05401
802-656-8990
Principal Investigator: Waheed Waqar
?
mi
from
Burlington, VT
Click here to add this to my saved trials
101 Jessup Hall
Iowa City, Iowa 52242
(319) 335-3500
Principal Investigator: Jeri Sieren
University of Iowa With just over 30,000 students, the University of Iowa is one of...
?
mi
from
Iowa City, IA
Click here to add this to my saved trials
920 Madison Ave
Memphis, Tennessee 38163
Principal Investigator: Tulio Bertorini
?
mi
from
Memphis, TN
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
(612) 625-5000
Principal Investigator: Gregg Meekins
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Albuquerque, New Mexico 87131
(505) 277-0111
Principal Investigator: Christopher Calder
University of New Mexico Founded in 1889 as New Mexico’s flagship institution, the University of...
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
655 West Baltimore Street
Baltimore, Maryland 21201
(410) 706-7410
Principal Investigator: Justin Kwan, MD
University of Maryland School of Medicine Established in 1807, The School of Medicine is the...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Baltimore, Maryland 21218
(410) 516-8000
Principal Investigator: Mohammed Khoshnoodi
Johns Hopkins The Johns Hopkins University opened in 1876, with the inauguration of its first...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Boston, Massachusetts
Principal Investigator: Michal Vytopil
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02111
Principal Investigator: Ken Gorson, Dr
?
mi
from
Boston, MA
Click here to add this to my saved trials
Buenos Aires,
Principal Investigator: Andres Berardo
?
mi
from
Buenos Aires,
Click here to add this to my saved trials
Buffalo, New York 14215
Principal Investigator: Nicholas Silvestri
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
303 East Superior Street
Chicago, Illinois 60611
Principal Investigator: Senda Ajroud-Driss
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Columbus, Ohio 43210
Principal Investigator: Amro Stino
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Grand Rapids, Michigan 49503
Principal Investigator: Paul Twydell
?
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Kazim Sheikh
?
mi
from
Houston, TX
Click here to add this to my saved trials
Jacksonville, Florida 32209
Principal Investigator: Michael Pulley
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Kansas, Kansas
Principal Investigator: Mazen Dimachkie
?
mi
from
Kansas, KS
Click here to add this to my saved trials
New Brunswick, New Jersey 08901
Principal Investigator: Shan Chen
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
333 Cedar St
New Haven, Connecticut 06504
(203) 432-4771
Principal Investigator: Richard Nowak
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New York, New York
Principal Investigator: Volkan Granit
?
mi
from
New York, NY
Click here to add this to my saved trials
New York, New York
Principal Investigator: Lan Zhou
?
mi
from
New York, NY
Click here to add this to my saved trials
New York City, New York 10032
Principal Investigator: Tom Brannagan
?
mi
from
New York City, NY
Click here to add this to my saved trials
Orange, California
Principal Investigator: Namita Goyal
?
mi
from
Orange, CA
Click here to add this to my saved trials
Phoenix, Arizona 85013
Principal Investigator: Shafeeq Ladha
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Salt Lake City, Utah 84132
Principal Investigator: Summer Karafiath
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
801 N Rutledge St
Springfield, Illinois 62702
(217) 545-8000
Principal Investigator: James Gilchrist
Southern Illinois University School of Medicine At SIU School of Medicine, research includes biologically oriented...
?
mi
from
Springfield, IL
Click here to add this to my saved trials